Hayflick limit

From WikiMD's Wellness Encyclopedia

Hayflick Limit refers to the phenomenon discovered by Leonard Hayflick in 1961, which states that a normal human cell has a fixed number of times that it can divide before cell division stops, known as cellular senescence. This concept challenged the prevailing belief at the time that cultured cells could proliferate indefinitely. Hayflick's discovery has profound implications for the study of aging, cancer, and cell biology.

Background[edit | edit source]

The Hayflick Limit is named after Leonard Hayflick, who, while working at the Wistar Institute in Philadelphia, observed that fibroblast cells derived from human fetal tissue could only divide a certain number of times. He found that these cells could divide approximately 50 times before entering a phase where they no longer proliferate, a state now known as senescence. This was in contrast to the prevailing view, based on work by Alexis Carrel, which suggested that cells could replicate indefinitely if provided with the right conditions.

Mechanism[edit | edit source]

The Hayflick Limit is closely associated with the length of telomeres, repetitive nucleotide sequences at the ends of chromosomes. With each cell division, telomeres shorten, acting as a kind of biological clock. Once telomeres reach a critically short length, cells enter senescence and cease to divide. This mechanism is thought to protect against cancer, as the unlimited division of cells with damaged DNA could lead to tumor formation.

Telomerase, an enzyme that adds nucleotide sequences to the ends of telomeres, can extend the lifespan of cells, including stem cells and cancer cells, which often express telomerase and can divide beyond the Hayflick Limit. This has implications for cancer research and regenerative medicine.

Implications[edit | edit source]

The Hayflick Limit has significant implications for various fields of biology and medicine. In aging research, it provides a cellular basis for the aging process and suggests potential interventions to extend healthspan. In cancer research, understanding how cancer cells bypass the Hayflick Limit can aid in the development of therapies that target these mechanisms. Additionally, the manipulation of telomerase activity in stem cells holds promise for regenerative medicine and tissue engineering.

Controversy[edit | edit source]

The discovery of the Hayflick Limit was initially controversial, as it contradicted the widely accepted belief in the immortality of cultured cells. Over time, however, Hayflick's findings were validated by other researchers, and the concept of the Hayflick Limit is now a fundamental principle in the study of cellular biology.

See Also[edit | edit source]

References[edit | edit source]




This gerontology related article is a stub. You can help WikiMD by expanding it.

WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD